Skip to main content
logo
Obigen Pharma Inc. (TPEX:7876)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.70
+0.30 (0.80%)
At close: Sep 7, 2026

Obigen Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
4,0314,170---
Market Cap Growth
-----
Enterprise Value
3,5983,605---
Last Close Price
37.7039.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
3.443.02---
P/TBV Ratio
7.125.52---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.050.060.060.060.04
Net Debt / Equity Ratio
-0.23-0.31-0.39-0.43-0.25
Net Debt / EBITDA Ratio
0.821.803.465.202.96
Net Debt / FCF Ratio
0.801.743.926.541.33
Quick Ratio
16.2617.2122.3239.2925.05
Current Ratio
18.1418.3022.4242.2628.78
Return on Equity (ROE)
-30.51%-21.32%-15.21%-14.36%-
Return on Assets (ROA)
-18.36%-12.96%-9.35%-8.84%-
Return on Capital Employed (ROCE)
-34.90%-23.40%-16.40%-12.60%-14.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-10.28%-7.82%---
FCF Yield
-8.33%-5.97%---
Buyback Yield / Dilution
-0.75%-0.22%-3.45%-34.82%-